May 13, 2016

According to the Alliance for Safe Biologic Medicines, the letter was spurred by the agency choosing a random suffix when it approved the second biosimilar earlier this year.

May 13, 2016

In the 2015 State of the Union address, President Barack Obama announced the launch of the Precision Medicine Initiative — a bold new research effort that can be actuated by MD Labs' Rxight, a pharmacogenetic program. 

May 13, 2016
The acquisition will bring Mylan some 25 branded and generic topical products alongside a pipeline of another 25 potential products.
May 12, 2016

Aurobindo’s generic Opana is indicated to help relieve moderate to sever pain in patients whose doctors have deemed the use of an opioid appropriate.

May 12, 2016

Mylan’s Frova generic is indicated to treat acute migraine headaches in adults.

May 11, 2016

By combining EHR data, historical patterns of flu activity and a machine-learning algorithm to interpret the data, the researchers made accurate predictions of national and local influenza activity.

May 10, 2016

A Forbes contributor on Monday offered an analysis of the recent record high in generics approvals by the Food and Drug Administration’s Office of Generic Drugs, and the importance that speedy approvals can play in helping patients. The analysis notes that speeding up FDA approval through user fee programs can be beneficial both for patients and manufacturers. (Forbes)

May 10, 2016

The study also notes that a solid portion of the excess cost — about $73 billion between 2010 and 2012 — was paid by consumers.

May 10, 2016

The drug treats hypertension in cases where patients can't be given an oral medication or has an urgent need to lower their blood pressure. 

May 9, 2016

The drug is indicated as an adjunct to diet to treat high cholesterol in adults with primary hypercholesterolemia or mixed dyslipidemia, as well as treatment of adults with severe hypertriglyceridemia. 

May 9, 2016

A record number of Americans showed up last weekend to turn in their unused prescription drugs, according to the Drug Enforcement Agency. 

May 3, 2016

The news comes as the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) seeks to reduce the number of antibiotic prescriptions by 15% by 2020.

May 3, 2016

Kenneth Parks will join the company on June 6 and will oversee all of Mylan’s global finance functions, including accounting and control, financial planning and analysis, investor relations, treasury and tax. 

 
May 2, 2016
The drug is indicated to treat acne vulgaris, and the company has already begun shipping to customers following FDA approval. 
 
April 29, 2016

The states with the highest rates of influenza, according to the Index, were Arizona, Texas, Kentucky, Mississippi and Tennessee.

April 29, 2016
The drug is indicated to treat high triglycerides, dysbetalipoproteinemia and high LDL cholesterol. It was approved in 5-, 10, 20-, and 40-mg dosage strengths, according to the FDA. 
April 27, 2016

 On Tuesday, the FDA approved Aurobindo’s generic Exforge (amlodipine and valsartan) tablets, and on Wednesday gave its OK to the company’s generic Opana (oxymorphone HCl) and Pepcid AC (famotidine). 

April 26, 2016

The researchers are currently conducting a National Health and Medical Research Council study using a combination of these nutraceuticals for depression.

April 26, 2016

A new partnership between the two companies will see development and commercialization of generics with a high technological barrier. 

April 25, 2016

The drug had an estimated market size of about $4.2 billion for the 12 months ending February 2016, according to IMS Health. 

April 25, 2016

Perrigo's new CEO led the company's U.S. Consumer Healthcare business from 2003 to 2006

April 22, 2016
The drug had U.S. sales of about $39 million for the 12 months ended December 2015, according to IMS Health. 
 
April 15, 2016

A new bill looks to push the FDA into rewriting a guidance on generic drug and biosimilar naming by withholding funding unless it meets Congress’ requests. 

April 14, 2016

In 2015, the OGD granted 580 approvals and 146 tentative approvals, including 99 in December alone – the largest number of drug approvals given out in a single month.